The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis

Journal of Clinical Investigation

Volumn 98, Issue 11, 1996, Pages 2436-2439

  Assoian, Richard K ^a   Marcantonio, Eugene E ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; CELL CYCLE; CELL TYPE; CORONARY ARTERY OBSTRUCTION; EXTRACELLULAR MATRIX; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0029806559     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119059     Document Type: Review

References (23)

1. Ohno, T., D. Gordon, H. San, V.J. Pompili, M.J. Imperiale, G.J. Nabel, and E.G. Nabel. 1994. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science (Wash. DC). 265:781-784.
2. Thyberg, J., U. Hedin, M. Sjvlind, L. Palmberg, and B.A. Bottger. 1990. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 10:966-990.
3. Chang, M.W., E. Barr, J. Seltzer, Y.-Q. Jiang, G.J. Nabel, E.G. Nabel, M.S. Parmacek, and J.M. Leiden. 1995. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science (Wash. DC). 267:518-522.
4. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323-330.
5. Böhmer, R.-M., E. Scharf, and R.K. Assoian. 1996. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol. Biol. Cell. 7:101-111.
6. Zhu, X., M. Ohtsubo, R.M. Böhmer, J.M. Roberts, and R.K. Assoian. 1996. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133:391-403.
7. Schulze, A., K. Thome-Zerfass, J. Bergès, S. Middendorp, P. Jansen-Dürr, and B. Henglein. 1996. Anchorage-dependent transcription of the cyclin A gene. Mol. Cell. Biol. 16:4632-4638.
8. Sherr, C.J., and J.M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
9. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-cdk2 kinase activity on cell anchorage. Science (Wash. DC). 271:499-502.
10. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270:23589-23597.
11. MAPK pathway. J. Biol. Chem. 271:20608-20616.
12. Hedin, U., B.A. Bottger, E. Forsberg, S. Johansson, and J. Thyberg. 1988. Diverse effects of fibronectin and laminin on phenotypic properties of cultured aortic smooth muscle cells. J. Cell Biol. 107:307-319.
13. von der Mark, K., and M. Öcalan. 1989. Antagonistic effects of laminin and fibronectin on the expression of the myogenic phenotype. Differentiation. 40:150-157.
14. Hynes, R.O. 1992. Integrins: versatility, modulation and signalling in cell adhesion. Cell. 69:11-25.
15. Ruoslahti, E., and J.C. Reed. 1994. Anchorage dependence, integrins, and apoptosis. Cell. 77:477-478.
16. Schaller, M.D., and J.T. Parsons. 1994. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. 6:705-710.
17. Schlaepfer, D.D., S.K., Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (Lond.). 372:786-791.
18. 2 but not for cytoskeletal organization. J Biol. Chem. 271: 14814-14818.
19. Chen, Q., T.H. Lin, C.J. Der, and R.L. Juliano. 1996. Integrin-mediated activation of MEK and mitogen-activaled protein kinase is independent of Ras. J. Biol. Chem. 271:18122-18127.
20. Renshaw, M.W., D. Toksoz, and M.A. Schwartz. 1996. Involvement of the small GTPase Rho in integrin-mediated activation of mitogen-activated protein kinase. J. Biol. Chem. 271:21691-21694.
21. Wary, K.K., F. Mainiero, S.J. Isakoff, E.E. Marcantonio, and F.G. Giancotti. 1996. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell. 87:733-743.
22. Skinner, M.P., E.W. Raines, and R. Ross. 1994. Dynamic expression of α1β1 and α2β1 integrin receptors by human vascular smooth muscle cells. Am. J. Pathol. 145:1070-1081.
23. Topol, E.J., R.M. Califf, H.F. Weisman, S.G. Ellis, J.E. Tcheng, S. Worley, R. Ivanhoe, B.S. George, D. Fintel, et al. 1994. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: results at six months. The EPIC Investigators. Lancet. 343: 881-886.